Last reviewed · How we verify
GN-037
At a glance
| Generic name | GN-037 |
|---|---|
| Sponsor | GEN İlaç ve Sağlık Ürünleri A.Ş. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis (PHASE2)
- Phase I Study of GN-037 Cream for Psoriasis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GN-037 CI brief — competitive landscape report
- GN-037 updates RSS · CI watch RSS
- GEN İlaç ve Sağlık Ürünleri A.Ş. portfolio CI